{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:41:41Z","timestamp":1789638101671,"version":"4.0.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["P30 AG010129"],"award-info":[{"award-number":["P30 AG010129"]}]},{"name":"NIH","award":["K01 AG030514"],"award-info":[{"award-number":["K01 AG030514"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.nmd.2013.09.008","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T01:04:52Z","timestamp":1379552692000},"page":"969-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms"],"prefix":"10.1016","volume":"23","author":[{"given":"F.L.","family":"Mastaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rojana-udomsart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Needham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Roses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.09.008_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2007.11.001","article-title":"Sporadic inclusion body myositis: a continuing puzzle","volume":"18","author":"Needham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.09.008_b0020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/NEN.0b013e31826183c8","article-title":"Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis","volume":"71","author":"Askanas","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nmd.2013.09.008_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nmd.2007.09.005","article-title":"Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal","volume":"18","author":"Needham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.09.008_b0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.410400223","article-title":"Apolipoprotein E alleles in sporadic inclusion-body myositis and hereditary inclusion-body myopathy","volume":"40","author":"Askanas","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.410400608","article-title":"Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies","volume":"40","author":"Mirabella","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2012.05.003","article-title":"High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes","volume":"250","author":"Rojana-udomsart","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2013.09.008_b0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneuroim.2012.09.003","article-title":"Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis","volume":"254","author":"Rojana-Udomsart","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2013.09.008_b0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2009.07.015","article-title":"Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype","volume":"19","author":"Mastaglia","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nmd.2013.09.008_b0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0960-8966(00)00144-9","article-title":"Mitochondrial DNA variants in inclusion body myositis","volume":"10","author":"Kok","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.nmd.2013.09.008_b0170","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.09.008_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.nmd.2013.09.008_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2011-110743","article-title":"TOMM40 rs10524523 polymorphism\u2019s role in late-onset Alzheimer\u2019s disease and in longevity","volume":"28","author":"Maruszak","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nmd.2013.09.008_b0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","article-title":"Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nmd.2013.09.008_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/clpt.2012.222","article-title":"Using genetics to enable studies on the prevention of Alzheimer\u2019s disease","volume":"93","author":"Crenshaw","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nmd.2013.09.008_b0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0095","doi-asserted-by":"crossref","first-page":"e30994","DOI":"10.1371\/journal.pone.0030994","article-title":"Characterization of the poly-T variant in the TOMM40 gene in diverse populations","volume":"7","author":"Linnertz","year":"2012","journal-title":"PLoS ONE"},{"issue":"Pt 2","key":"10.1016\/j.nmd.2013.09.008_b0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/116.2.325","article-title":"Mitochondrial DNA deletions in inclusion body myositis","volume":"116","author":"Oldfors","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2013.09.008_b0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410390615","article-title":"Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients","volume":"39","author":"Santorelli","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00005072-199805000-00003","article-title":"Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis","volume":"57","author":"Horvath","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001756-199612200-00031","article-title":"Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis","volume":"8","author":"Yang","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.nmd.2013.09.008_b0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/aws046","article-title":"Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1beta-induced accumulation of beta-amyloid and cell death","volume":"135","author":"Schmidt","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2013.09.008_b0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archneur.55.7.915","article-title":"Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging?","volume":"55","author":"Askanas","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2013.09.008_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","article-title":"Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"4","author":"Hashimoto","year":"2003","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.nmd.2013.09.008_b0135","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","article-title":"Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition","volume":"66","author":"Askanas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2013.09.008_b0140","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1073\/pnas.93.3.1314","article-title":"Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle","volume":"93","author":"Askanas","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.09.008_b0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2013.09.008_b0150","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheime\u2019s disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nmd.2013.09.008_b0155","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","article-title":"Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42","volume":"25","author":"Crouch","year":"2005","journal-title":"J Neurosci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:42Z","timestamp":1760774502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613009607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0960896613009607"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.09.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}